Global Ozempic Market By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Mar 2025
- Report ID: 141449
- Number of Pages: 370
- Format:
-
-
-
- Novo Nordisk A/S Company Profile
- Mylan
- Hanmi Pharmaceutical
- Gmax Biopharm
- Eli Lilly
- Boehringer Ingelheim
- Biolingus
- AstraZeneca Plc Company Profile
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible